Takamatsu Red Cross Hospital

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg et al. · Blood · 2017 · 590 citations · Full text

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri et al. · Blood · 2018 · 394 citations · Full text

WHO histologic classification is a prognostic indicator in thymoma

Kazuya Kondo, Kiyoshi YOSHIZAWA, Masaru Tsuyuguchi et al. · The Annals of Thoracic Surgery · 2004 · 318 citations · Full text

Medicine, Surgical Pathology, Histopathology +5

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

Masatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 303 citations

Hepatology, Medicine, Clinical Trials +10

Treatment and survival among 1594 patients with ATL

Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya et al. · Blood · 2015 · 302 citations · Full text